These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 16943580)
1. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580 [TBL] [Abstract][Full Text] [Related]
2. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
4. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
5. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [TBL] [Abstract][Full Text] [Related]
6. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816 [TBL] [Abstract][Full Text] [Related]
7. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in nonobese patients with polycystic ovary syndrome. Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861 [TBL] [Abstract][Full Text] [Related]
9. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
10. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome. Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395 [TBL] [Abstract][Full Text] [Related]
11. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters. Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590 [TBL] [Abstract][Full Text] [Related]
12. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034 [TBL] [Abstract][Full Text] [Related]
13. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Yucel A; Noyan V; Sagsoz N Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726 [TBL] [Abstract][Full Text] [Related]
14. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241 [TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related]